and assaying antibody-secreting cells. New technology allows researchers to assay thousands of single primary antibody-secreting cells in just one day.

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.

Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new grant from the Gates ...

Vaccine effectiveness relies on creating a strong antibody response that can be reactivated to fight future infections. Now, ...

Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...

Abbreviations: APRIL = a proliferation-inducing ligand; ASC = antibody-secreting cell; B = B cell; BAFF = B-cell-activating factor; BAFF-R = B-cell-activating factor receptor; BCMA = B-cell ...

The study also simulates an AbD workflow, using Cyto-Mine ® Chroma to precisely isolate rare cells secreting antigen-specific antibodies. Utilizing a viability dye alongside IgG-specific probes ...

However, the addition of anti-CD9 antibodies ensured that they only captured EVs ... The team also identified several key features of the captured high-secreting cells: they displayed increased ...

Clonal colonies of transfected CHO, HEK293 or myeloma cells secreting a recombinant protein of interest are probed in situ with target protein–specific, fluorophore-conjugated antibody ...

Cells were identified and isolated based on productivity (IgG secretion) and antigen specificity (antibody-antigen binding) while maintaining high accuracy. In alignment with AbD workflows ...

Vaxart (VXRT) announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly ...